Abstract

Aim Polymorphisms in the promoter region of the β-fibrinogen gene are associated with increased plasma fibrinogen levels. We investigated whether the distribution of the C148T polymorphism is associated with an increase in cardiovascular risk.

Methods and Results In a nested case-control design, the distribution of the C148T polymorphism was investigated among 751 participants in the Physicians' Health Study who subsequently developed myocardial infarction, stroke or venous thromboembolism (cases) and among 751 age- and smoking-matched controls over follow-up of 8·6 years. Frequency of the T allele was similar among men who had myocardial infarction (22·7%, P=0·5), stroke (18·4%, P=0·2) or venous thromboembolism (17·0%, P=0·1) compared with those with no cardiovascular events (21·5%). The relative risk for any vascular event among men homozygous or heterozygous for the T allele compared with men homozygous for the C allele was 0·94 (95% CI 0·76–1·16). We found no evidence of an association between the T allele and myocardial infarction (relative risk 1·06; 95% CI 0·82–1·36), stroke (0·87, 0·63–1·21) or venous thromboembolism (0·75; 0·51–1·08). Analysis adjusted for aspirin use and traditional cardiovascular risk factors had no significant effect on these findings.

Conclusion In a large prospective cohort, carriage of the T allele for the C148T mutation in the β-fibrinogen promoter gene was not associated with an increased subsequent risk of cardiovascular events.

f1
Correspondence: Dr Paul M. Ridker, Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215, U.S.A.

References

1
Wilhelmsen
L
, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction.
N Engl J Med
 .
1984
;
311
:
501
–505
2
Ma
J
, Hennekens CH, Ridker PM, Stampfer MJ. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study.
J Am Coll Cardiol
 .
1999
;
33
:
1347
–1352
3
Koster
T
, Rosendaal FR, Reitsma PH, van der Velden PA, Briet E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms—the Leiden Thrombophilia Study (LETS).
Thromb Haemost
 .
1994
;
71
:
719
–722
4
Roy
SN
, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen.
J Biol Chem
 .
1990
;
265
:
6389
–6393
5
Iso
H
, Folsom AR, Winkelmann JC. Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples.
Thromb Haemost
 .
1995
;
73
:
106
–111
6
van't Hooft
FM
, von Bahr SJ, Silveira A, Iliadou A, Eriksson P, Hamsten A. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration.
Arterioscler Thromb Vasc Biol
 .
1999
;
19
:
3063
–3070
7
Behague
I
, Poirier O, Nicaud V. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde.
Circulation
 .
1996
;
93
:
440
–449
8
Baumann
RE
, Henschen AH. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster.
Hum Genet
 .
1994
;
94
:
165
–170
9
Schmidt
H
, Schmidt R, Niederkorn K. Beta-fibrinogen gene polymorphism (C148T) is associated with carotid atherosclerosis: results of the .Austrian Stroke Prevention Study.
Arterioscler Thromb Vasc Biol
 .
1998
;
18
:
487
–492
10
Nishiuma
S
, Kario K, Yakushijin K. Genetic variation in the promoter region of the beta-fibrinogen gene is associated with ischemic stroke in a Japanese population.
Blood Coagul Fibrinolysis
 .
1998
;
9
:
373
–379
11
Lam
KS
, Ma OC, Wat NM, Chan LC, Janus ED. Beta-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes.
Diabetologia
 .
1999
;
42
:
1250
–1253
12
Tybjaerg-Hansen
A
, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG. A common mutation (G-455-A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.
J Clin Invest
 .
1997
;
99
:
3034
–3039
13
Scarabin
PY
, Bara L, Ricard S. Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study.
Arterioscler Thromb
 .
1993
;
13
:
886
–891
14
Doggen
CJ
, Bertina RM, Cats VM, Rosendaal FR. Fibrinogen polymorphisms are not associated with the risk of myocardial infarction.
Br J Haematol
 .
2000
;
110
:
935
–938
15
Lee
AJ
, Fowkes FG, Lowe GD, Connor JM, Rumley A. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study.
Thromb Haemost
 .
1999
;
81
:
553
–560
16
N Engl J Med
 .
1989
;
321
:
129
–135
17
Ridker
PM
, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.
N Engl J Med
 .
1995
;
332
:
912
–917
18
Humphries
SE
, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L. European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction.
Arterioscler Thromb Vasc Biol
 .
1995
;
15
:
96
–104

Comments

0 Comments